Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy.

Leiser, Dominic; Calaminus, Gabriele; Malyapa, Robert; Bojaxhiu, Beat; Albertini, Francesca; Kliebsch, Ulrike; Mikroutsikos, Lorentzos; Morach, Petra; Bolsi, Alessandra; Walser, Marc; Timmermann, Beate; Lomax, Tony; Schneider, Ralf; Weber, Damien Charles (2016). Tumour control and Quality of Life in children with rhabdomyosarcoma treated with pencil beam scanning proton therapy. Radiotherapy and oncology, 120(1), pp. 163-168. Elsevier 10.1016/j.radonc.2016.05.013

[img] Text
1-s2.0-S0167814016311161-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (424kB)

PURPOSE

To assess clinical outcomes in children with rhabdomyosarcoma (RMS) treated with pencil beam scanning (PBS) proton therapy (PT).

METHODS AND MATERIALS

Eighty-three RMS (embryonal, n=74; 89%) patients treated between January 2000 and December 2014 were included. The median age was 4.5years (range, 0.8-15.5). All patients received systemic chemotherapy according to prospective protocols. Patients had low-, intermediate-, and high-risk disease in 24%, 63%, and 13% of cases, respectively. The median total dose delivered was 54Gy(RBE) (range, 41.4-64.8).

RESULTS

After a median follow-up time of 55.5 months (range, 0.9-126.3), local failure occurred in 16 patients. The 5-year local-control survival rate was 78.5% [95% confidence interval (CI), 69.5-88.5%]. Significant predictors for local failure were group/stage, tumour location, and size. Fourteen patients (16%) died, all from tumour progression. The 5-year overall survival was 80.6% (95%CI, 71.8-90.0%). The 5-year incidence of grade 3 non-ocular late toxicity was 3.6% (95%CI, 1-12%). No grade 4-5 late toxicities were observed. One radiation-induced malignancy was observed (1.2%). The Quality of Life (QoL) scores increased significantly after PT compared to baseline values.

CONCLUSIONS

PBS PT led to excellent outcome in children with RMS. Late non-ocular toxicity was minimal and QoL good.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology

UniBE Contributor:

Leiser, Dominic, Bojaxhiu, Beat, Weber, Damien Charles

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0167-8140

Publisher:

Elsevier

Language:

English

Submitter:

Beatrice Scheidegger

Date Deposited:

05 Apr 2017 08:09

Last Modified:

05 Dec 2022 15:01

Publisher DOI:

10.1016/j.radonc.2016.05.013

PubMed ID:

27247053

Uncontrolled Keywords:

Children; Late toxicity; Pencil beam scanning proton therapy; Quality of Life; Radiation-induced tumours; Rhabdomyosarcoma

BORIS DOI:

10.7892/boris.93415

URI:

https://boris.unibe.ch/id/eprint/93415

Actions (login required)

Edit item Edit item
Provide Feedback